Medtronic plc (NYSE:MDT) Q2 2023 Earnings Call Transcript

And overall, with respect to the contribution, as you mentioned, I think it’s early to call that, but given our system is now installed around the world in markets in APAC, EMEA, Lat-Am. We just received regulatory approvals and indication expansions in Japan, which is the third largest robotics market in the world. We have general surgery approval in the EU, Canada and Australia, which opens up the hernia market for us. And we have started to see really strong presence at some really key congresses in Europe where live stream cases, etcetera. So, a little early to call it contribution, Joanne, but we are starting to see the momentum and the acceleration that we talked about. Thank you.

Brad Welnick: Thanks Joanne.

Geoff Martha: Thank you, Joanne.

Ryan Weispfenning: Geoff, please go ahead with your closing remarks.

Geoff Martha: Okay. Thanks Ryan. Well, first of all, thank you everybody for the questions. And we do really appreciate your support and continued interest in Medtronic. And we look forward to updating you on our progress on our Q3 earnings broadcast, which we anticipate holding on February 21. So with that, thanks again for tuning in today. Please stay healthy and safe. I understand there is a lot of people traveling this holiday. And for those of you in the U.S., I would like to wish you and your families a very happy Thanksgiving.